A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors

por Papadopoulos, Kyriakos P, Tsai, Frank, Hamid, Omid, Xiao, Feng, Steele, Keith E, Rebelatto, Marlon C, Robbins, Paul B, Karakunnel, Joyson J, Lai, Dominic W, Mahipal, Amit
Publicado 2015

Phase Ib/II study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) and tremelimumab as monotherapy or in combination, in patients with recurrent or metastatic...

por Kelly, Ronan J, Chung, Ki, Gu, Yu, Steele, Keith E, Rebelatto, Marlon C, Robbins, Paul B, Tavakkoli, Fatemeh, Karakunnel, Joyson J, Lai, Dominic W, Almhanna, Khaldoun
Publicado 2015